• Accreditation

    The Congress of Neurological Surgeons is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    CME Credit

    This activity has been approved for AMA PRA Category 1 Credit™.

    The scientific program is currently being evaluated. Please check back for the approved credit total.

    Disclosures

    The Accreditation Council for Continuing Medical Education Standards for Commercial Support requires that anyone in a position to control the content of the educational activity has disclosed all financial relationships with any commercial interest. Failure or refusal to disclose or the inability to satisfactorily resolve the identified conflict may result in the withdrawal of the invitation to participate in any of the CNS educational activities. The ACCME defines a “commercial interest” as any entity producing, marketing, reselling, or distributing healthcare goods or services consumed by, or used on, patients. It is also each speaker’s responsibility to include the FDA clearance status of any device or drug requiring FDA approval discussed or described in their presentation or to describe the lack of FDA clearance for any “off label” uses discussed. Speakers from the audience are also required, therefore, to indicate any relevant personal/professional relationships as they discuss a given topic.

    A listing of all Annual Meeting disclosures will be distributed to attendees on-site at the meeting.

    FDA Statement

    Some drugs or medical devices demonstrated at the Annual Meeting have not been cleared by the FDA or have been cleared by the FDA for specific purposes only. The FDA has stated that it is the responsibility of the physician to determine the FDA clearance status of each drug or medical device he or she wishes to use in clinical practice. The CNS policy provides that “off label” uses of a drug or medical device may be described at the Annual Meeting so long as the “off label” use of the drug or medical device is also specifically disclosed. Any drug or medical device is “off label” if the described use is not set forth on the product’s approval label. It is also each speaker’s responsibility to include the FDA clearance status of any device or drug requiring FDA approval discussed or described in their presentation or to describe the lack of FDA clearance for any “off label” uses discussed. Speakers from the audience are also required, therefore, to indicate any relevant personal/professional relationships as they discuss a given topic.

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site here. Privacy Policy